Drugs / streptodornase
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04252963 | Nov 2018 → Feb 2021 | bronchitis, upper respiratory tract disorder | Hanmi Pharmaceutical Company Limited | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | streptodornase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04252963 ↗ |
| Known as | Estreptodornasa | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108867 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL2108867 ↗ |